WOLVERINE ASSET MANAGEMENT LLC
Position in NAMS — NewAmsterdam Pharma Co N.V.
CIK 1279891
CHICAGO, IL
Position in NAMS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$318,947
+$276,322 QoQ
Shares Held
14,925
+601.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#144
of 197 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WOLVERINE ASSET MANAGEMENT LLC holds $7,557,835 across 33 Biotechnology names. NAMS ranks #7 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GOSS |
Gossamer Bio, Inc.
|
161,184 | $2,127,633 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
22,340 | $1,771,338 | |
| 3 | 10,909 | $1,447,951 | |||
| 4 | TECH |
BIO-TECHNE Corp
|
10,471 | $739,776 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
2,330 | $561,460 | |
| 6 | NVAX |
Novavax Inc
|
37,037 | $348,888 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
This page
|
14,925 | $318,947 | |
| 8 | IMCR |
Immunocore Holdings plc
|
2,822 | $89,598 |
All Filings in NAMS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $70,580 | 2,012 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $69,080 | 2,429 | Shares | Defined | 2025-10-28 | |
| 2024-09-30 | $82,070 | 4,944 | Shares | Defined | 2024-11-04 | |
| 2024-06-30 | $298,216 | 15,524 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $168,624 | 7,130 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $97,111 | 8,694 | Shares | Defined | 2024-02-01 | |
| 2023-09-30 | $27,056 | 2,925 | Shares | Defined | 2023-11-13 | |
| 2023-03-31 | $63,899 | 4,819 | Shares | Defined | 2023-05-08 | |
| No filing history on record for this holder in this stock. | ||||||